Advertisement
Screener

Quantum Cyber N.V. (QUCY) Income (Loss) from Continuing Operations, Per Diluted Share

0.8 / 5 stars · 3/18 Roast Me

Quantum Cyber N.V. Income (Loss) from Continuing Operations, Per Diluted Share

Quantum Cyber N.V. (QUCY) reported Income (Loss) from Continuing Operations, Per Diluted Share of -$0.56 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare · last filed 2026-08-14

  • Quantum Cyber N.V. income (loss) from continuing operations, per diluted share for the quarter ending 2026-06-30 was -$0.56.
  • Quantum Cyber N.V. income (loss) from continuing operations, per diluted share for the quarter ending 2026-03-31 was -$0.21.
  • Quantum Cyber N.V. income (loss) from continuing operations, per diluted share for the quarter ending 2025-06-30 was -$0.39.
  • Quantum Cyber N.V. income (loss) from continuing operations, per diluted share for the quarter ending 2025-03-31 was -$0.81.
Period endIncome (Loss) from Continuing Operations, Per Diluted Share 3 monthIncome (Loss) from Continuing Operations, Per Diluted Share 6 month
2026-06-30-$0.56
10-Q · filed 2026-08-14
-$0.85
10-Q · filed 2026-08-14
2026-03-31-$0.21
10-Q · filed 2026-05-15
2025-06-30-$0.39
10-Q · filed 2026-08-14
-$1.14
10-Q · filed 2026-08-14
2025-03-31-$0.81
10-Q · filed 2026-05-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Immuneering Corp (IMRX)United States$0.113B-12.51
BICYCLE THERAPEUTICS PLC (BCYC)$0.112B-1.56
GENELUX Corp (GNLX)United States$0.110B-3.83
Equillium, Inc. (EQ)United States$0.109B-11.27
Biomea Fusion, Inc. (BMEA)United States$0.107B-3.30
OnKure Therapeutics, Inc. (OKUR)United States$0.119B-3.13
Polaryx Therapeutics, Inc. (PLYX)United States$0.106B
Coya Therapeutics, Inc. (COYA)United States$0.121B-6.35
CUMBERLAND PHARMACEUTICALS INC (CPIX)United States$0.121B-8.95
Aardvark Therapeutics, Inc. (AARD)United States$0.121B-1.80